Literature DB >> 1499675

A study into the mechanism of the Crystal Violet reaction in Staphylococcus aureus.

M R Barer1, D Burdess, R Freeman.   

Abstract

The mechanism of the Crystal Violet (CV) reaction, a trait which has been related to biotype, source and pathogenicity in Staphylococcus aureus, was investigated in agar and broth studies. White reactions could be converted to purple and vice versa by altering the incubation conditions on agar. Broth reactions examined macroscopically and by spectrophotometry revealed that both white and purple human biotype strains take up CV but the former then progressively modify the dye more quickly than the latter. A cell-associated product of CV was detected in white and purple strains by reverse-phase thin-layer chromatography of methanol extracts. White strains appear to produce a second additional product from CV. The white reaction was not inhibited by chloramphenicol or azide but did depend on viable cells with a nutrient source. CV MICs and MBCs for 10 white and 10 purple reactors showed no gross differences in susceptibility, while a standardized assay for the rate of CV modifying activity (52 strains) demonstrated that the two categories comprise discrete populations which alter CV at different rates. Although most white strains belong to either or both of phage-typing groups V and II, purple strains with this pattern of susceptibility and white strains without it both occur. The capacity to modify CV slowly or rapidly appears to subdivide human biotype strains independently of their phage group and is associated in the former case with their capacity to produce hospital-acquired and invasive infections.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1499675      PMCID: PMC2272239     

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  9 in total

1.  Correlation between staphylococcal phage groups and some staphylococcal enzymes demonstrated by simple methods.

Authors:  T M VOGELSANG; A WORMNES; B OSTERVOLD
Journal:  Acta Pathol Microbiol Scand       Date:  1962

2.  Biochemical characteristics and enterotoxigenicity of Staphylococcus aureus strains isolated from poultry.

Authors:  P A Gibbs; J T Patterson; J Harvey
Journal:  J Appl Bacteriol       Date:  1978-02

3.  Animal fecal carriership and biotypes of Staphylococcus aureus.

Authors:  G Dimitracopoulos; H Kalkani-Boussiakou; J Papavassiliou
Journal:  Appl Environ Microbiol       Date:  1977-11       Impact factor: 4.792

4.  [The differentiation of pathogenic staphylococci and a suggestion for their taxonomic classification].

Authors:  V Hájek; E Marsálek
Journal:  Zentralbl Bakteriol Orig A       Date:  1971-06

5.  Crystal violet reactions of fresh clinical isolates of Staphylococcus aureus from two British hospitals.

Authors:  R Freeman; S J Hudson; D Burdess
Journal:  Epidemiol Infect       Date:  1990-12       Impact factor: 2.451

6.  Rosanilins: indicator dyes for chloramphenicol-resistant enterobacteria containing chloramphenicol acetyltransferase.

Authors:  G N Proctor; R H Rownd
Journal:  J Bacteriol       Date:  1982-06       Impact factor: 3.490

7.  Crystal violet binding, cell surface properties and extracellular enzyme profiles of Staphylococcus aureus producing toxic shock syndrome toxin-1.

Authors:  A S Naidu; J Jimenez; J Rollof; P Aleljung; P Nilsson-Ehle; L Larsson; S A Hedström
Journal:  Zentralbl Bakteriol       Date:  1989-05

8.  Prevalence of staphylococcal zoonosis in pyogenic skin infections.

Authors:  P N Rao; A S Naidu; P R Rao; K Rajyalakshmi
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1987-06

9.  Levels of toxic shock syndrome toxin-1 production among Staphylococcus aureus strains and clinical implications.

Authors:  A S Naidu; C Kamme; A Ljungh; T Wadström
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1989-01
  9 in total
  1 in total

1.  Crystal violet reactions of coagulase negative staphylococci.

Authors:  R Freeman; D Burdess; S Smith
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.